Literature DB >> 19754427

IRAK1-independent pathways required for the interleukin-1-stimulated activation of the Tpl2 catalytic subunit and its dissociation from ABIN2.

Hosea Handoyo1, Margaret J Stafford, Eamon McManus, Dionissios Baltzis, Mark Peggie, Philip Cohen.   

Abstract

The protein kinase Tpl2 (tumour progression locus 2) is activated by LPS (lipopolysaccharide), TNFalpha (tumour necrosis factor alpha) and IL (interleukin)-1. Activation of the native Tpl2 complex by these agonists requires the IKKbeta {IkappaB [inhibitor of NF-kappaB (nuclear factor kappaB)] kinase beta}-catalysed phosphorylation of the p105/NF-kappaB1 subunit and is accompanied by the release of the catalytic subunit from both p105/NF-kappaB1 and another subunit ABIN2 (A20-binding inhibitor of NF-kappaB 2). In the present study we report that IL-1 activates the transfected Tpl2 catalytic subunit in an HEK (human embryonic kidney)-293 cell line that stably expresses the IL-1R (IL-1 receptor), but does not express the protein kinase IRAK1 (IL-1R-associated kinase). In these cells IL-1 does not activate IKKbeta or induce the phosphorylation of p105/NF-kappaB1, and nor does the IKKbeta inhibitor PS1145 prevent the IL-1-induced activation of transfected Tpl2. However, the IL-1-stimulated activation of transfected Tpl2 in IRAK1-null cells or activation of the endogenous Tpl2 complex in IRAK1-expressing cells is suppressed by the protein kinase inhibitor PP2 by a mechanism that does not involve inhibition of Src family protein tyrosine kinases. The IL-1-stimulated activation of transfected Tpl2 is accompanied by its phosphorylation at Thr290 and Ser400 and by enhanced phosphorylation of Ser62, which we demonstrate are autophosphorylation events catalysed by Tpl2 itself. We further show that IL-1 triggers the dissociation of Tpl2 from co-transfected ABIN2 in IRAK1-null IL-1R cells, which is not suppressed by PP2 or by the inhibition of Tpl2 or IKKbeta. These studies identify two new signalling events involved in activation of the native Tpl2 complex by IL-1. First, the IRAK1-, IKKbeta- and PP2-independent dissociation of Tpl2 from ABIN2; secondly, the IRAK1- and IKKbeta-independent, but PP2-sensitive, activation of the Tpl2 catalytic subunit.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19754427     DOI: 10.1042/BJ20091271

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  6 in total

1.  Cot/tpl2 (MAP3K8) mediates myeloperoxidase activity and hypernociception following peripheral inflammation.

Authors:  Irene Soria-Castro; Agnieszka Krzyzanowska; Marta López Pelaéz; Javier Regadera; Gema Ferrer; Lluis Montoliu; Rosario Rodríguez-Ramos; Margarita Fernández; Susana Alemany
Journal:  J Biol Chem       Date:  2010-08-24       Impact factor: 5.157

2.  Role of Ca2+/calmodulin-dependent kinase II-IRAK1 interaction in LMP1-induced NF-κB activation.

Authors:  Jung-Eun Kim; Sang Yong Kim; Sue Yeon Lim; Elliott Kieff; Yoon-Jae Song
Journal:  Mol Cell Biol       Date:  2013-11-18       Impact factor: 4.272

Review 3.  Regulation and function of TPL-2, an IκB kinase-regulated MAP kinase kinase kinase.

Authors:  Thorsten Gantke; Srividya Sriskantharajah; Steven C Ley
Journal:  Cell Res       Date:  2010-12-07       Impact factor: 25.617

4.  Tumor progression locus 2 (Tpl2) deficiency does not protect against obesity-induced metabolic disease.

Authors:  Graeme I Lancaster; Greg M Kowalski; Emma Estevez; Michael J Kraakman; George Grigoriadis; Mark A Febbraio; Steve Gerondakis; Ashish Banerjee
Journal:  PLoS One       Date:  2012-06-11       Impact factor: 3.240

5.  IκB kinase 2 regulates TPL-2 activation of extracellular signal-regulated kinases 1 and 2 by direct phosphorylation of TPL-2 serine 400.

Authors:  Karine Roget; Abduelhakem Ben-Addi; Agnes Mambole-Dema; Thorsten Gantke; Huei-Ting Yang; Julia Janzen; Nick Morrice; Derek Abbott; Steven C Ley
Journal:  Mol Cell Biol       Date:  2012-09-17       Impact factor: 4.272

6.  The protein kinase TPL2 is essential for ERK1/ERK2 activation and cytokine gene expression in airway epithelial cells exposed to pathogen-associated molecular patterns (PAMPs).

Authors:  Guy Martel; Julie Bérubé; Simon Rousseau
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.